Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 9/20 | 0.59 |
| ▸ | GAA | P10253 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.51 |
| ▸ | HPGD | P15428 | 4/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10148330 | 0.91 | L3MBTL1 (0.54) | L3MBTL1MAPTGAAALDH1A1HPGD | |
| SCHEMBL10185083 | 0.85 | MAPT (0.48) | L3MBTL1MAPTGAAALDH1A1HPGD | |
| SCHEMBL19510704 | 0.85 | L3MBTL1 (0.46) | L3MBTL1MAPTGAAALDH1A1HPGD | |
| SCHEMBL30350660 | 0.85 | L3MBTL1 (0.46) | L3MBTL1MAPTGAAALDH1A1HPGD | |
| SCHEMBL10148316 | 0.85 | FFAR4 (0.48) | L3MBTL1MAPT | |
| SCHEMBL25035144 | 0.83 | L3MBTL1 (0.45) | L3MBTL1MAPTGAAALDH1A1HPGD | |
| SCHEMBL10148314 | 0.83 | ALDH1A1 (0.55) | L3MBTL1MAPTGAAALDH1A1HPGD | |
| SCHEMBL31334246 | 0.81 | MAPT (0.61) | MAPTALDH1A1LMNASMN1; SMN2KMT2A | |
| SCHEMBL180951 | 0.81 | GPR119 (0.48) | MAPTGAAALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL31467934 | 0.79 | L3MBTL1 (0.56) | L3MBTL1MAPTGAAALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120046292-A1 | DIACYLETHYLENEDIAMINE COMPOUND | ASTELLAS PHARMA INC. (JP) | 2012-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046292-A1 | DIACYLETHYLENEDIAMINE COMPOUND | DGAT1, DGAT2, DIMT1 | L3MBTL1 607/4885MAPT 2628/4885GAA 183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.